Jeffrey S. Farrow, Chief Financial Officer at Global Blood Therapeutics, Inc. (GBT), sold 33,326 shares at $68.00 ($2.3M) on 2022-09-01, disclosed to the SEC on 2022-09-06.
Open-market sale of $2.3M GBT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.00 | 31,441 | $2.1M | 94.3% |
| 2 | $68.15 | 1,885 | $128K | 5.7% |
| Total | $68.01 avg | 33,326 | $2.3M | 100% |
| Filing → |
| TARS | SELL | 2025-06-18 | $1.1M | — | Filing → |
| TARS | SELL | 2025-03-20 | $357K | — | Filing → |
| TARS | SELL | 2024-06-20 | $574K | — | Filing → |